Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.

Literature DB >> 15875225

Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.

I Mohammedi¹, M A Piens, C Padoin, D Robert.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2005 PMID： 15875225 DOI： 10.1007/s10096-005-1325-7

Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN： 0934-9723 Impact factor: 3.267

× No keyword cloud information.

11 in total

1. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit.

Authors: T Staudinger; B Stoiser; M Müllner; G J Locker; K Laczika; S Knapp; H Burgmann; A Wilfing; J Kofler; F Thalhammer; M Frass
Journal: Crit Care Med Date: 2000-05 Impact factor: 7.598

2. Has antifungal susceptibility testing come of age?

Authors: John H Rex; Michael A Pfaller
Journal: Clin Infect Dis Date: 2002-09-24 Impact factor: 9.079

3. Development and validation of a high-performance liquid chromatography assay for voriconazole.

Authors: Gennethel J Pennick; Martin Clark; Deanna A Sutton; Michael G Rinaldi
Journal: Antimicrob Agents Chemother Date: 2003-07 Impact factor: 5.191

4. The epidemiology of sepsis in the United States from 1979 through 2000.

Authors: Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal: N Engl J Med Date: 2003-04-17 Impact factor: 91.245

5. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.

Authors: L Purkins; N Wood; P Ghahramani; K Greenhalgh; M J Allen; D Kleinermans
Journal: Antimicrob Agents Chemother Date: 2002-08 Impact factor: 5.191

Review 6. Current and emerging azole antifungal agents.

Authors: D J Sheehan; C A Hitchcock; C M Sibley
Journal: Clin Microbiol Rev Date: 1999-01 Impact factor: 26.132

7. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.

Authors: J R Le Gall; S Lemeshow; F Saulnier
Journal: JAMA Date: 1993 Dec 22-29 Impact factor: 56.272

8. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication.

Authors: Dominique D Benoit; Koenraad H Vandewoude; Johan M Decruyenaere; Eric A Hoste; Francis A Colardyn
Journal: Crit Care Med Date: 2003-01 Impact factor: 7.598

Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.

1. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit.

2. Has antifungal susceptibility testing come of age?

3. Development and validation of a high-performance liquid chromatography assay for voriconazole.

4. The epidemiology of sepsis in the United States from 1979 through 2000.

5. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.

Review 6. Current and emerging azole antifungal agents.

7. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.

8. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication.

Review 9. Voriconazole: a new triazole antifungal agent.

10. Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.

Review 1. Antifungal therapeutic drug monitoring: established and emerging indications.

2. What is the role of therapeutic drug monitoring in antifungal therapy?

3. Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.

4. Pharmacokinetics of posaconazole administered orally or by nasogastric tube in healthy volunteers.

5. Decrease of voriconazole trough levels during therapy with enteral nutrition: a case report.